AU2003202878B2 - Dab9 derivatives of lipopeptide antibiotics and methods of making and using the same - Google Patents

Dab9 derivatives of lipopeptide antibiotics and methods of making and using the same Download PDF

Info

Publication number
AU2003202878B2
AU2003202878B2 AU2003202878A AU2003202878A AU2003202878B2 AU 2003202878 B2 AU2003202878 B2 AU 2003202878B2 AU 2003202878 A AU2003202878 A AU 2003202878A AU 2003202878 A AU2003202878 A AU 2003202878A AU 2003202878 B2 AU2003202878 B2 AU 2003202878B2
Authority
AU
Australia
Prior art keywords
different
same
substituted
groups
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2003202878A
Other languages
English (en)
Other versions
AU2003202878A1 (en
Inventor
Vincent A. Boyd
Dale Cameron
Maria Fardis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biowest Therapeutics Inc
Original Assignee
Migenix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Migenix Inc filed Critical Migenix Inc
Publication of AU2003202878A1 publication Critical patent/AU2003202878A1/en
Application granted granted Critical
Publication of AU2003202878B2 publication Critical patent/AU2003202878B2/en
Assigned to MIGENIX INC. reassignment MIGENIX INC. Alteration of Name(s) of Applicant(s) under S113 Assignors: MICROLOGIX BIOTECH INC.
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003202878A 2002-01-03 2003-01-02 Dab9 derivatives of lipopeptide antibiotics and methods of making and using the same Ceased AU2003202878B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US45371002P 2002-01-03 2002-01-03
US10/039,516 2002-01-03
PCT/US2003/000158 WO2003057724A1 (en) 2002-01-03 2003-01-02 Dab9 DERIVATIVES OF LIPOPEPTIDE ANTIBIOTICS AND METHODS OF MAKING AND USING THE SAME

Publications (2)

Publication Number Publication Date
AU2003202878A1 AU2003202878A1 (en) 2003-07-24
AU2003202878B2 true AU2003202878B2 (en) 2008-07-31

Family

ID=33131662

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003202878A Ceased AU2003202878B2 (en) 2002-01-03 2003-01-02 Dab9 derivatives of lipopeptide antibiotics and methods of making and using the same

Country Status (6)

Country Link
US (3) US7125844B2 (enExample)
EP (1) EP1481005A1 (enExample)
JP (1) JP4402463B2 (enExample)
AU (1) AU2003202878B2 (enExample)
CA (1) CA2471458A1 (enExample)
WO (1) WO2003057724A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1481005A1 (en) * 2002-01-03 2004-12-01 Micrologix Biotech, Inc. Dab sp 9 /sp DERIVATIVES OF LIPOPEPTIDE ANTIBIOTICS AND METHODS OF MAKING AND USING THE SAME
AU2004252174A1 (en) 2003-06-26 2005-01-06 Migenix Inc. Compositions of lipopeptide antibiotic derivatives and methods of use thereof
WO2007092633A2 (en) * 2006-02-09 2007-08-16 Elevance Renewable Sciences, Inc. Antimicrobial compositions, methods and systems
US7951232B2 (en) * 2006-02-09 2011-05-31 Elevance Renewable Sciences, Inc. Surface coating compositions and methods
GB0821540D0 (en) 2008-11-25 2008-12-31 Merlion Pharmaceuticals Pte Ltd Lipopeptide compounds and their use
US9504756B2 (en) * 2012-05-15 2016-11-29 Seattle Genetics, Inc. Self-stabilizing linker conjugates
BR112019001945A2 (pt) 2016-08-09 2019-05-07 Seattle Genetics, Inc. composição de conjugado de fármaco aglutinante, formulação farmaceuticamente aceitável, métodos para tratar uma doença ou afecção hiperproliferativa, para inibir a multiplicação de uma célula tumoral ou célula cancerígena e para preparar uma composição de conjugado de fármaco aglutinado, e, composto

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB923544A (en) 1959-07-21 1963-04-10 Takeda Pharmaceutical A new antibiotic-glumamycin
US3057779A (en) 1960-03-14 1962-10-09 American Cyanamid Co Antibiotic and production thereof
US3639582A (en) 1967-04-14 1972-02-01 Zaidan Hojin Biseibutsu Antibiotic laspartomycin
DE1800363A1 (de) 1967-10-04 1969-07-03 Shionogi & Co Tsushimycin und seine Herstellung
FR2124060B1 (enExample) 1971-02-02 1974-04-12 Rhone Poulenc Sa
US4524135A (en) 1982-05-21 1985-06-18 Eli Lilly And Company A-21978C cyclic peptides
ZA883887B (en) 1987-06-10 1990-02-28 Lilly Co Eli Chromatographic purification process
US5039789A (en) 1988-04-11 1991-08-13 Eli Lilly And Company A54145 cyclic peptides
US4994270A (en) 1988-04-11 1991-02-19 Eli Lilly And Company A54145 antibiotics and process for their production
US5028590A (en) 1988-04-11 1991-07-02 Eli Lilly And Company Derivatives of A54145 cyclic peptides
US4977083A (en) 1988-04-11 1990-12-11 Eli Lilly And Company Processes for preparing A54145 compounds
TW455591B (en) * 1993-06-08 2001-09-21 Hoechst Ag Lipopeptides from actinoplanes sp. with pharmacological action, process for their production and the use thereof
DE4411025A1 (de) 1994-03-30 1995-10-05 Hoechst Ag Lipopeptid-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
WO1997047738A1 (en) 1996-06-13 1997-12-18 Fujisawa Pharmaceutical Co., Ltd. Cyclic lipopeptide acylase
DE19807972A1 (de) 1998-02-25 1999-08-26 Hoechst Marion Roussel De Gmbh Lipopeptidantibiotika-Calciumsalze, Verfahren zu ihrer Herstellung und Verwendung
US6716962B2 (en) 2000-07-17 2004-04-06 Micrologix Biotech Inc. Extractive purification of lipopeptide antibiotics
US6750199B2 (en) * 2000-07-17 2004-06-15 Micrologix Biotech Inc. Antimicrobial sulfonamide derivatives of lipopeptide antibiotics
AU7893301A (en) 2000-07-17 2002-01-30 Intrabiotics Pharmaceuticals Antimicrobial sulfonamide derivatives of lipopeptide antibiotics
EP1481005A1 (en) * 2002-01-03 2004-12-01 Micrologix Biotech, Inc. Dab sp 9 /sp DERIVATIVES OF LIPOPEPTIDE ANTIBIOTICS AND METHODS OF MAKING AND USING THE SAME

Also Published As

Publication number Publication date
CA2471458A1 (en) 2003-07-17
US7655623B2 (en) 2010-02-02
JP4402463B2 (ja) 2010-01-20
WO2003057724A1 (en) 2003-07-17
US20100137199A1 (en) 2010-06-03
EP1481005A1 (en) 2004-12-01
JP2005524622A (ja) 2005-08-18
US20070167357A1 (en) 2007-07-19
AU2003202878A1 (en) 2003-07-24
US20040138107A1 (en) 2004-07-15
US7125844B2 (en) 2006-10-24

Similar Documents

Publication Publication Date Title
US7868135B2 (en) Compositions of lipopeptide antibiotic derivatives and methods of use thereof
AU2009211287B2 (en) Short fatty acid tail polymyxin derivatives and uses thereof
US11046730B2 (en) Antimicrobial compositions
US20100137199A1 (en) Dab9 DERIVATIVES OF LIPOPEPTIDE ANTIBIOTICS AND METHODS OF MAKING AND USING THE SAME
AU735283B2 (en) Blocking expression of virulence factors in (s. aureus)
IL109917A (en) Lipopeptides from actinoplanes sp with pharmacological action process for their preparation and the use thereof
US6498238B1 (en) Glycopeptide antibacterial compounds, compositions containing same and methods of using same
CN101522705B (zh) 来自actinomadura namibiensis的抗菌和抗病毒肽
US6511962B1 (en) Derivatives of laspartomycin and preparation and use thereof
WO2001081373A2 (en) Glycopeptide antibacterial compounds and methods of using same
EP0337731A2 (en) Peptide antibiotics
HU193528B (en) Process for preparing a-219780 cyclic peptide-acil derivatives
US7144858B2 (en) Antibacterial compounds and methods for treating Gram positive bacterial infections
US6737403B2 (en) Derivatives of laspartomycin and preparation and use thereof
AU2013257422B2 (en) Short fatty acid tail polymyxin derivatives and uses thereof
EP4132945A2 (en) Antibacterial lipopeptides, pharmaceutical composition and cosmetic composition comprising them, and uses thereof
MXPA06000525A (en) Compositions of lipopeptide antibiotic derivatives and methods of use thereof
HK1135708B (en) Antibacterial and antiviral peptides from actinomadura namibiensis

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired